Monday, February 26, 2024
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Japan approves new Merck Covid-19 pill

Tokyo, Dec 24 (Prensa Latina) Japan´s Health Ministry has approved today an oral Covid-19 drug developed by the US pharmaceutical firm Merck & Co, making it the first such pill to be used in the country.

Molnupiravir, which prevents the novel coronavirus from multiplying in the body, was given the green light under a fast-track process after MSD K.K., the Japanese arm of Merck, applied in early December to produce and sell the drug in Japan.

In an interim report on clinical trials in Japan, Europe, and the United States, Merck initially reported that Molnupiravir halves the risk of hospitalization and death.

The Japanese subsidiary has said that molnupiravir is also likely effective against the Omicron variant of the virus. Patients 18 or older with mild symptoms will be able to take the pill twice a day for five days.

Prime Minister Fumio Kishida said that 200,000 doses of the pill would be delivered nationwide from this weekend if approved. The government has already agreed with Merck on the procurement of 1.6 million doses.

Health minister Shigeyuki Goto said the drug was expected to be available at medical institutions as early as Monday. The ministry will work with drugstores to enable the treatment to be taken at home to reduce contact between patients and others.

Molnupiravir, also approved in Britain in November, has drawn attention as the world’s first approved Covid-19 treatment that can be taken orally. But British regulators have not recommended its use for pregnant women, and it is not approved for children.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.